Mortality in Pregnant Women with COVID-19 in Mexico | Chapter 10 | Novel Research Aspects in Medicine and Medical Science Vol. 5

 During the universal by SARS-CoV-2 the pregnant women, crowd older than 60 age, lung problems (asthma, COPD), myocardial infarction, brain and nervous system environments, cancer and sure blood disorders, weakened invulnerable system, chronic kind, liver disease, insane health condition, down disease and kids under 5 years are considered a group of risk, even though pregnant girls infected with SARS-COV-2 are mainly asymptomatic or present mild COVID-19 very analogous to non-pregnant women. The aim is review the humanness by COVID-19 in pregnant women in Mexico.Sever severe respiratory disease coronavirus 2 (SARS-CoV-2) is a virus that are more similar to sock coronavirus than human SARS.  COVID-19 starts as a pneumonia case with unfamiliar study of animal and origin, The coronavirus affliction 19 is a highly transmittable and pathogenic zealous infection caused by harsh acute respiring syndrome coronavirus 2. Genomic analysis told that SARS-CoV-2 is phylogenetically related to severe severe respiratory disease-like (SARS-like) bat viruses, therefore sock could be the possible basic reservoir. Main manifestations reported in COVID 19: fever, dry cough, asthenia, myalgia, arthralgias, difficulty chills, odynophagia and dyspnea. Anosmia, ageusia, diarrhea, disgorging, nasal congestion and hemoptysis are less average.According to different studies made in Mexico, skilled is no evidence that pregnant women are more naive to severe SARS-CoV-2 contamination. However, they being considered as a population group in danger, it has been shown that equating other comorbidities to a degree pneumonia, asthma, COPD and even the increase in age, they are susceptible to the increase mortality rate and problems in patients afflicted by COVID 19.

Author(s) Details:

Michelle Arias-Morales,
Department of Research and Technological Development, Teaching and Research Directorate, Institute of Public Health from Guanajuato State, Mexico and School of Medicine, Quetzalcoatl University in Irapuato, Mexico.

Edith Fernanda Villanueva Mendez,
Department of Research and Technological Development, Teaching and Research Directorate, Institute of Public Health from Guanajuato State, Mexico and School of Medicine, Quetzalcoatl University in Irapuato, Mexico.

Luis Ignacio Pérez-Velázquez,
Department of Research and Technological Development, Teaching and Research Directorate, Institute of Public Health from Guanajuato State, Mexico and Division of Health Sciences, Campus Leon, University of Guanajuato, Mexico.

Maria de Jesús Gallardo-Luna,
Department of Research and Technological Development, Teaching and Research Directorate, Institute of Public Health from Guanajuato State, Mexico.

Gilberto Flores-Vargas,
Department of Research and Technological Development, Teaching and Research Directorate, Institute of Public Health from Guanajuato State, Mexico.

Efraín Navarro-Olivos,
Teaching and Research Directorate, Institute of Public Health from Guanajuato State, Mexico.

Nicolás Padilla-Raygoza,
Department of Research and Technological Development, Teaching and Research Directorate, Institute of Public Health from Guanajuato State, Mexico.

Please see the link here: https://stm.bookpi.org/NRAMMS-V5/article/view/12170

Fatality of Cases by New Coronavirus Disease (COVID 19): A Case Study in the Mexican State of Guanajuato | Chapter 04 | New Horizons in Medicine and Medical Research Vol. 9

 The goal of this research is to explain the COVID-19 pandemic and report on fatalities in the Mexican state of Guanajuato until October 2, 2020.

The National Epidemiological Surveillance System Database from Mexico was used for this study. Age, sex, comorbidities (diabetes, COPD, asthma, hypertension, cardiovascular disease, immunosuppression, chronic renal disease, obesity, and smoking), date of death, and real-time reverse transcription polymerase test results were all collected. In statistical analysis, the Case Fatality Ratio, Chi-squared test, and P-value were used to show relationships between variables. The impact of comorbidities on death from COVID-19 was demonstrated using the odds ratio and 95 percent confidence intervals. The statistical relationships were also determined using a Bayesian network model. risk factors, comorbidities, and mortality There were 100,109 suspected cases, with 41.69 percent of them testing positive for SARS-CoV-2. COVID-19 discovered that being over 60 and male had a higher risk of death. In Guanajuato State, 1,457 fatalities (48.68 percent) happened in the Mexican Institute of Social Security, with a case fatality ratio of 15.63 percent; meanwhile, 1,260 deaths (42.10 percent) occurred in the Ministry of Health, with a case fatality ratio of 4.14 percent. Diabetes (OR 5.16, CI95 percent 4.77–5.59), chronic obstructive pulmonary disease (OR 6.34, CI95 percent 5.37–7.49), immunosuppression (OR 2.85, CI95 percent 2.17–3.76), cardiovascular disease (OR 4.20, CI95 percent 3.51–5.02), hypertension (OR 4.74, CI95 percent 4.39–5.11), chronic kidney disease (OR 6.27, CI95 percent 5.30–7.42), COVID-19 has an influence on death.

Age and sex were the two most important risk variables for mortality among COVID-19 patients in Guanajuato. Diabetes, COPD, immunosuppression, cardiovascular disease, chronic renal disease, obesity, and smoking, on the other hand, are all variables that increase the chance of mortality. On the other hand, comorbidities and risk factors are strongly linked. SARS-CoV-2 disease lethality is unaffected by HIV/AIDS, however asthma appears to be protective.


Author(S) Details

Efrain Navarro-Olivos
Directorate of Teaching and Research, Institute of Public Health from Guanajuato State, Guanajuato, Mexico.

Gilberto Flores-Vargas
Department of Research and Technological Development, Directorate of Teaching and Research, Institute of Public Health from Guanajuato State, Guanajuato, Mexico.

Maria de Jesus Gallardo-Luna
Department of Research and Technological Development, Directorate of Teaching and Research, Institute of Public Health from Guanajuato State, Guanajuato, Mexico.

Francisco Javier Magos-Vazquez
Directorate of Health Services, Institute of Public Health from Guanajuato State, Guanajuato, Mexico.

Daniel Alberto Diaz-Martinez
Directorate of Health Services, Institute of Public Health from Guanajuato State, Guanajuato, Mexico.

Nicolas Padilla-Raygoza
Department of Research and Technological Development, Directorate of Teaching and Research, Institute of Public Health from Guanajuato State, Guanajuato, Mexico.

View Book:- https://stm.bookpi.org/NHMMR-V9/article/view/6897

A Recent Study on the Global Epidemiology of the COVID-19 Pandemic: A Population-level Observation till the End of 2020 | Chapter 6 | Highlights on Medicine and Medical Science Vol. 13

 A new study looked at epidemiological data from 17 nations during the first 90 days of the coronavirus disease-2019 (COVID-19) lockdown in Wuhan, China. However, in order to take preventative steps, it is necessary to grasp the current world scenario. The goal of this research is to look at the global epidemiology of the COVID-19 pandemic from 212 nations through 2020. We used data from worldometers.info until December 31, 2020 to conduct this population-level observational analysis. Case rates, active cases, recovery rates, severe cases, death, and case fatality were among the epidemiological parameters examined. Despite a global recovery rate of 70.78%, mortality and case fatality rates are 0.02 percent and 2.18 percent, respectively. Andorra (1041%) has a high prevalence of instances, while Martinique (9769%), France (9012%), and Belgium (9009%) have a high incidence of active cases. Despite the large number of patients in Guinea-Bissau (50 percent), Antiqua and Barbuda (16.67 percent), and Saudi Arabia (13.81 percent), the recovery rate is approximately 90%. Both severe cases (24.21% ) and case fatality rates (29.06%) are high in Yemen; nevertheless, the recovery rate is somewhat over the national average of 66.41%. The recovery rates in Macao, Marshal Island, New Caledonia, and Singapore are all 100%. Worldwide, the recovery rate is high, and the death rate is low. In Yemen, however, the condition is extremely severe. For the international scientific community, these findings allow constant surveillance of the COVID-19 pandemic.

Author (S) Details

Vishal Vennu
Department of Rehabilitation Sciences, College of Applied Medical Sciences, King Saud University, 10219 Riyadh 11433, Saudi Arabia.

View Book :- https://stm.bookpi.org/HMMS-V13/article/view/2725